Companies β€Ί Delenex Therapeutics

Delenex Therapeutics

Healthcare πŸ“ ZΓΌrich, Switzerland πŸ‘₯ 1-10 employees πŸ’° $41.3M raised πŸ“… Founded 2009

Delenex Therapeutics AG is a Swiss biotech company developing therapeutic antibody fragments targeting serious medical diseases with high unmet need. The company's fragments are being designed for local/topical application by using the benefits of an antibody therapy with only limited systemic exposure. Its clinically

πŸ“Š Company Overview

Sector
Healthcare
Country
Switzerland
Employees
1-10
Total Raised Β· Venture
$41.3M
Founded
2009
Cloud
Unknown

☁️ Cloud Infrastructure

πŸ”’ Subscribers only Cloud Provider
WorkspaceπŸ”’ Subscribers only
CDNπŸ”’ Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

πŸ’° Estimated Cloud Spend

$18K – $45K / year across cloud providers

πŸ›  Tech Stack & Marketing

Ad PlatformsπŸ”’ Subscribers only
Analytics & CRMπŸ”’ Subscribers only
CMS / PlatformπŸ”’ Subscribers only
Frontend StackπŸ”’ Subscribers only

Detected from Delenex Therapeutics's public homepage as of 2026-06-13.

πŸ” Compare with Similar Companies

Same sector (Healthcare), similar size

Data detected 2026-06-13 Β· Methodology Β· Suggest a correction